Efficacy of atropine sulfate/obidoxime chloride co-formulation against Sarin. (cas 107-44-8)exposure in guinea pigs

Add time:08/21/2019    Source:sciencedirect.com

The efficacy and pharmacokinetics of the aqueous co-formulation contents of the Trobigard™ (atropine sulfate, obidoxime chloride) auto-injector were evaluated in a sarin exposed guinea pig model. Two subcutaneous (sc) sarin challenge doses were evaluated in guinea pigs instrumented with brain and heart electrodes for electroencephalogram (EEG) and electrocardiogram (ECG). Sarin challenge doses were chosen to reflect exposure subclasses with sublethal (moderate to severe clinical signs) and lethal consequences. The level of protection of intramuscular human equivalent doses of the co-formulation was defined by (1) the mitigation of signs and symptoms at a sublethal level and (2) the increase of survival time at the supralethal sarin dose levels.Pharmacokinetics of both atropine sulfate and obidoxime were proportional at 1 and 3 human equivalent doses, and only a small increase in heart rate was observed briefly as a side effect.At both sarin challenge doses, 54 μg/kg and 84 μg/kg, the co-formulation treatment was effective against sarin-induced effects. Survival rates were improved at both sarin challenge levels, whereas clinical signs and changes in EEG activity could not in all cases be effectively mitigated, in particular at the supralethal sarin challenge dose level. Reactivation of sarin inhibited cholinesterase was observed in blood, and higher brain cholinesterase activity levels were associated with a better clinical condition of the co-formulation treated animals.Although the results cannot be directly extrapolated to the human situation, pharmacokinetics and the effects over time related to plasma levels of therapeutics in a freely moving guinea pig could aid translational models and possibly improve prediction of efficacy in humans.

We also recommend Trading Suppliers and Manufacturers of Sarin. (cas 107-44-8). Pls Click Website Link as below: cas 107-44-8 suppliers

Prev:Full Length ArticleTime dependent dual effect of anti-inflammatory treatments on Sarin. (cas 107-44-8)induced brain inflammation: Suggested role of prostaglandins
Next:Full Length ArticleSex modulated effects of Sarin. (cas 107-44-8)exposure in rats: Toxicity, hypothermia and inflammatory markers)